David Geffen School of Medicine

Los Angeles, California 90095-7059

1 studies enrolling now · 11 studies all time

What they study most

Alpha 1-Antitrypsin Deficiency, Emphysema, Extensive Stage-small Cell Lung Cancer, Invasive Fungal Infection, Leukemia, Male Hypogonadism, Pancreatic Cancer, Pulmonary Disease, Chronic Obstructive, Relapsed/Refractory Chronic Lymphocytic Leukemia, Richter's Syndrome, Sarcoidosis, Pulmonary, Small Lymphocytic Lymphoma

Studies at this site

• A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) — Recruiting now
• Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome — Running, not enrolling
• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling
• Financial Incentives for Smoking Treatment II — Running, not enrolling
• A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy — Completed
• Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema — Completed
• Registry of Patients Treated With Systemic Mold-Active Triazoles — Completed
• Acthar Gel in Participants With Pulmonary Sarcoidosis — Completed
• Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer — Completed
• Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men — Completed
• Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease — Completed